Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedOct 30, 2024Phenylephrine HCl 0.9% Sodium Chloride Injection USPcGMP violationsFresenius Kabi Compounding, LLC · D-0016-2025Class IITerminatedOct 30, 2024Phenylephrine HCl 0.9% Sodium Chloride Injection USPcGMP violationsFresenius Kabi Compounding, LLC · D-0015-2025Class IITerminatedOct 30, 2024Phenylephrine HCl 0.9% Sodium Chloride Injection USPCGMP violationsFresenius Kabi Compounding, LLC · D-0014-2025Class IIOngoingOct 23, 2024First Aid Antiseptic OintmentIncorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in...Zhejiang Jingwei Pharmaceutical Co., Ltd. · D-0013-2025Class ITerminatedOct 23, 2024Atovaquone Oral SuspensionMicrobial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.Bionpharma Inc. · D-0012-2025Class IIOngoingOct 23, 2024Dapsone Gel 7.5%CrystallizationViona Pharmaceuticals Inc · D-0011-2025Class IITerminatedOct 23, 2024Cisplatin InjectionFailed Impurities/Degradation Specifications.Accord Healthcare, Inc. · D-0010-2025Class IICompletedOct 23, 2024Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc · D-0009-2025Class IOngoingOct 16, 2024Vail-Bon Jie Yang Wan capsulesMarketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.123Herbals · D-0008-2025Class IIOngoingOct 9, 2024PluvictoCGMP deviationsAdvanced Accelerator Applications USA, Inc. · D-0007-2025Class IIOngoingOct 9, 2024RyaltrisDefective Delivery System: The dip tube is clogged causing the spray not to work.Glenmark Pharmaceuticals Inc., USA · D-0006-2025Class ITerminatedOct 9, 2024VekluryPresence of Particulate Matter: Presence of glass particle.Gilead Sciences, Inc. · D-0005-2025Class IOngoingOct 9, 2024Gold Hard Steel Plus LiquidMarketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.Supercore Products Group Inc. · D-0004-2025Class IOngoingOct 9, 2024Hard Steel CapsulesMarketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.Supercore Products Group Inc. · D-0003-2025Class IIIOngoingOct 9, 2024Ciclopirox Gel 0.77%Defective Container: Firm received complaints of broken tube at the seal.Glenmark Pharmaceuticals Inc., USA · D-0002-2025Class IITerminatedOct 9, 2024Atorvastatin Calcium TabletsPresence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.Nivagen Pharmaceuticals Inc · D-0001-2025Class IIOngoingOct 2, 2024Mycophenolic Acid Delayed-Release Tablets USPFailed Dissolution SpecificationsAscend Laboratories, LLC · D-0668-2024Class IIOngoingOct 2, 2024EnviroClean Hand Sanitizer GelCGMP deviationsEnviroServe Chemicals Inc. · D-0667-2024Class IIOngoingOct 2, 2024Infla-650 Herbal Dietary SupplementMarketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.Guru Inc. · D-0666-2024Class IIOngoingOct 2, 2024Refresh LACRI-LUBELack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.AbbVie Inc. · D-0665-2024Class IIOngoingOct 2, 2024Refresh P.MLack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.AbbVie Inc. · D-0664-2024Class IITerminatedOct 2, 2024Pyridoxine HCLLack of Assurance of SterilityEmpower Pharmacy · D-0663-2024Class IIOngoingOct 2, 2024Vivier Sheer SPF 30 Mineral With AntioxidantsMicrobial Contamination of Non-Sterile ProductVivier Pharma, Inc. · D-0662-2024Class IITerminatedOct 2, 2024Proparacaine Hydrochloride Ophthalmic SolutionTemperature abuse: Products exposed to improper temperature above drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0661-2024Class IICompletedOct 2, 2024Mupirocin OintmentSubpotent DrugGlenmark Pharmaceuticals Inc., USA · D-0660-2024Class IIIOngoingSep 25, 2024AcetaZOLAMIDE TabletsDiscolorationRubicon Research Private Limited · D-0659-2024Class IIITerminatedSep 18, 2024Just Right 5000LABELING: LABEL MIX-UP.Elevate Oral Care · D-0658-2024Class IIOngoingSep 18, 2024BARRIER THERAPY SKIN PROTECTANT CREAMMicrobial contamination of non-sterile Products -Prequel Skin · D-0657-2024Class IIOngoingSep 11, 2024TIRZEPATIDE 60 mg/3mLLack of Assurance of SterilityProRx LLC · D-0656-2024Class IIOngoingSep 11, 2024TIRZEPATIDE 20 mg/2mLLack of Assurance of SterilityProRx LLC · D-0655-2024Class IIOngoingSep 11, 2024Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mLLack of Assurance of SterilityProRx LLC · D-0654-2024Class IIOngoingSep 11, 2024SEMAGLUTIDE 10mg/4mLLack of Assurance of SterilityProRx LLC · D-0653-2024Class IIOngoingSep 11, 2024SEMAGLUTIDE 5mg/2mLLack of Assurance of SterilityProRx LLC · D-0652-2024Class IIOngoingSep 11, 2024Tirzepatide 2 mLLack of Assurance of SterilityProRx LLC · D-0651-2024Class IIOngoingSep 11, 2024SemaglutideLack of Assurance of SterilityProRx LLC · D-0650-2024Class IOngoingSep 11, 2024HeparinMicrobial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.Baxter Healthcare Corporation · D-0649-2024Class IITerminatedSep 4, 2024Cefixime for Oral Suspension USPSubpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.Lupin Pharmaceuticals Inc. · D-0648-2024Class IIOngoingSep 4, 2024Ibuprofen TabletsFailed Impurities/Degradation Specifications - at 18-month Stability testingPreferred Pharmaceuticals, Inc. · D-0647-2024Class IIOngoingSep 4, 2024IBU Ibuprofen TabletsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.Dr. Reddy's Laboratories, Inc. · D-0646-2024Class IIOngoingSep 4, 2024IBU Ibuprofen TabletsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.Dr. Reddy's Laboratories, Inc. · D-0645-2024

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.